232 related articles for article (PubMed ID: 8580883)
1. Minnesota Multiphasic Personality Inventory correlates of panic disorder with agoraphobia: changes with treatment.
Ito LM; Gorenstein C; Gentil V; Miyakawa E
Braz J Med Biol Res; 1995 Sep; 28(9):961-5. PubMed ID: 8580883
[TBL] [Abstract][Full Text] [Related]
2. Influence of psychological factors on the response to clomipramine in hospitalized chronic low back pain patients. Preliminary data from a psychometric study.
Fouquet B; Goupille P; Jeannou J; Etienne T; Chalumeau F; Valat JP
Rev Rhum Engl Ed; 1997 Dec; 64(12):804-8. PubMed ID: 9476269
[TBL] [Abstract][Full Text] [Related]
3. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
4. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
[TBL] [Abstract][Full Text] [Related]
5. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
[TBL] [Abstract][Full Text] [Related]
6. Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder.
Koszycki D; Zacharko RM; Bradwejn J
Psychiatry Res; 1996 May; 62(2):131-8. PubMed ID: 8771610
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
Marcourakis T; Gorenstein C; Ramos RT; da Motta Singer J
J Psychopharmacol; 1999; 13(1):40-4. PubMed ID: 10221358
[TBL] [Abstract][Full Text] [Related]
8. The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial.
Fahy TJ; O'Rourke D; Brophy J; Schazmann W; Sciascia S
J Affect Disord; 1992 May; 25(1):63-75. PubMed ID: 1624646
[TBL] [Abstract][Full Text] [Related]
9. Imipramine for vestibular dysfunction in panic disorder: a prospective case series.
Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE
Arq Neuropsiquiatr; 2011 Apr; 69(2A):196-201. PubMed ID: 21537560
[TBL] [Abstract][Full Text] [Related]
10. The use of the Panic and Agoraphobia Scale in a clinical trial.
Bandelow B; Brunner E; Broocks A; Beinroth D; Hajak G; Pralle L; Rüther E
Psychiatry Res; 1998 Jan; 77(1):43-9. PubMed ID: 10710174
[TBL] [Abstract][Full Text] [Related]
11. Memory performance in panic disorder patients after chronic use of clomipramine.
de Carvalho SC; Marcourakis T; Artes R; Gorenstein C
J Psychopharmacol; 2002 Sep; 16(3):220-6. PubMed ID: 12236628
[TBL] [Abstract][Full Text] [Related]
12. Clomipramine treatment of panic disorder: pros and cons.
Papp LA; Schneier FR; Fyer AJ; Leibowitz MR; Gorman JM; Coplan JD; Campeas R; Fallon BA; Klein DF
J Clin Psychiatry; 1997 Oct; 58(10):423-5. PubMed ID: 9375591
[TBL] [Abstract][Full Text] [Related]
13. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
Mavissakalian MR
Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
[TBL] [Abstract][Full Text] [Related]
14. Personality profiles of patients with dysthymic and panic disorder.
Batinic B; Saula-Marojevic B; Vukosavljevic-Gvozden T
Psychiatr Danub; 2013 Jun; 25(2):115-22. PubMed ID: 23793274
[TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
[TBL] [Abstract][Full Text] [Related]
16. A dose-finding and discontinuation study of clomipramine in panic disorder.
Lotufo-Neto F; Bernik M; Ramos RT; Andrade L; Gorenstein C; Cordas T; Melo M; Gentil V
J Psychopharmacol; 2001 Mar; 15(1):13-7. PubMed ID: 11277602
[TBL] [Abstract][Full Text] [Related]
17. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
[TBL] [Abstract][Full Text] [Related]
18. Heightened embarrassability discriminates between panic disorder patients with and without agoraphobia.
Swoboda H; Demal U; Krautgartner M; Amering M
J Behav Ther Exp Psychiatry; 2003; 34(3-4):195-204. PubMed ID: 14972667
[TBL] [Abstract][Full Text] [Related]
19. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
20. Predictors of outcome in panic disorder: a 5-year prospective follow-up study.
Scheibe G; Albus M
J Affect Disord; 1996 Nov; 41(2):111-6. PubMed ID: 8961038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
